In summary, in vivo and in vitro experiments in this study showed that si-PDGFRβ-loaded exosomes may protect against glioma progression by preventing the activity of the PI3K/Akt/EZH2 signaling pathway. This evidence concerns the gene EZH2 and central nervous system cancer.